Results 151 to 160 of about 4,589,938 (338)

Evaluation of Contraindication of Thrombolytic Therapy and Its Causes after AMI in Hamadan Ekbatan Hospital in 2002

پزشکی بالینی ابن سینا, 2005
Acute myocardial infarction (AMI ) is one of the most common cause of mortality in almost all countries of the world. According to this fact that thrombus formation and coronary obstruction are the basic pathophysiology of AMI , early    thrombolysis and
Shahram Homayonfar, Amin Bahreini, Morteza Jalilvand   +2 more
doaj  

Clinical and pathological findings in giraffes (Giraffa camelopardalis) with arterial thrombotic disease

Veterinary Record Case Reports, Volume 13, Issue 4, December 2025.
Abstract Two adult female giraffes (Giraffa camelopardalis) from separate facilities were diagnosed with arterial thrombotic disease. The first giraffe presented with acute severe unilateral hindlimb paralysis. Infrared thermography revealed a marked temperature decrease compared to the contralateral limb starting from the mid‐thigh region, indicative ...
Pierre Huberdeau, Benjamin Lamglait, Sylvie Laidebeure, Pierre Hélie, Shannon T. Ferrell, Marion Desmarchelier, Emilie L. Couture, Alexis Lécu   +7 more
wiley   +1 more source

Effect of Cardiac Rehabilitation on Cardiovascular Events in Patients With Advanced Chronic Kidney Disease

Therapeutic Apheresis and Dialysis, Volume 29, Issue 6, Page 856-865, December 2025.
ABSTRACT Introduction Little is known about the effect of cardiac rehabilitation (CR) on cardiovascular events in patients with advanced chronic kidney disease (CKD). Methods We performed a retrospective cohort study in 189 patients with an estimated glomerular filtration rate of less than 30 mL/min/1.73 m2 who were referred to our outpatient CR center.
Tomoaki Hama, Takatoshi Kakuta, Kazushige Amano, Akiko Ushijima, Fuminobu Yoshimachi, Yuji Ikari   +5 more
wiley   +1 more source

Thrombolytic therapy in prosthetic valve thrombosis in the second trimester of pregnancy

, 2020
Santhosh Jadhav, H.S. Natraj Setty, Sandeep Shankar, Phani Teja Mundru, M.C. Yeriswamy, Babu Reddy, Jayashree Kharge, Sathwik Raj, Arunkumar Ullegaddi, Rahul Patil, T.R. Raghu, C.N. Manjunath   +11 more
openalex   +2 more sources

Markers of Giant Cell Arteritis in Patients Presenting With Ischemic Stroke: A Scoping Review

European Journal of Neurology, Volume 32, Issue 12, December 2025.
Giant cell arteritis should be considered in patients aged ≥ 50 years presenting with vertebrobasilar ischemic events, multifocal infarcts affecting both vertebrobasilar and carotid territories, or recurrent ischemic events despite optimal secondary prevention.
Alain‐Mauricio Vergara, Marco Perez‐Caceres, Maxime Chayer‐Lanthier, Carolyn Ross, Jean‐Paul Makhzoum, Sylvain Lanthier   +5 more
wiley   +1 more source

Low-dose thrombolytic therapy for infrainguinal graft occlusions: An idea whose time has passed? [PDF]

, 1985
Bruce A. Perler, Robert I. White, Calvin B. Ernst, George M. Williams   +3 more
openalex   +1 more source

The origin of thrombolytic therapy

Journal of the American College of Cardiology, 1989
The origin of thrombolytic therapy is briefly reviewed. It began 40 years ago with the demonstration that the injection into patients of a partially purified activator of the native plasminogen-plasmin enzyme system was capable of dissolving clotted blood and fibrinous loculations in the chest.
openaire   +2 more sources

Molecular Characterization of the Group A Streptococcus Virulence‐Regulatory System FasBCAX

Molecular Microbiology, Volume 124, Issue 6, Page 521-537, December 2025.
The Fas system of the group A Streptococcus is comprised of three proteins (FasBCA) and a small regulatory RNA (FasX), and it represses adhesin production while also promoting the production of the spreading factor streptokinase. Here, we analyze the Fas proteins to assess how they positively regulate FasX production.
Sushila Baral, Roshika Roshika, Clay P. Renshaw, Ameya Singh, Ashna Prabhu, Ira Jain, Rebekah Woolsey, David Quilici, Yftah Tal‐Gan, Paul Sumby   +9 more
wiley   +1 more source

Which patients benefit most from early thrombolytic therapy with intracoronary streptokinase? [PDF]

, 1986
Frank Vermeer, Maarten L. Simoons, Frits W. Bär, Jan G.P. Tijssen, Ron T. van Domburg, Patrick W. Serruys, Freek W.A. Verheugt, J C, C. de Zwaan, Arnoud van der Laarse   +9 more
openalex   +1 more source

Cerebral hemorrhagic risk of aspirin or heparin therapy with thrombolytic treatment in rabbits. [PDF]

, 1991
Wayne M. Clark, K P Madden, Patrick D. Lyden, Justin A. Zivin   +3 more
openalex   +1 more source